# The Influence of Different Sera on the Anti-Infective Properties of Silver Nitrate in Biopolymer Coatings

## TL;DR

This paper explores how silver nitrate in biopolymer coatings can inhibit bacteria like Staphylococcus epidermidis, even in the presence of different sera, offering potential for preventing joint infections.

## Contribution

The study introduces a silver nitrate-embedded biopolymer coating that maintains antibacterial efficacy across various serum environments.

## Key findings

- Silver nitrate in biopolymer coatings significantly inhibits S. epidermidis growth in different serum conditions.
- The coating does not interact adversely with serum proteins, preserving antimicrobial effectiveness.
- The results suggest potential clinical use for reducing periprosthetic joint infections.

## Abstract

The widespread prevalence of periprosthetic joint infections (PJIs) poses significant challenges in orthopedic surgeries, with pathogens such as Staphylococcus epidermidis being particularly problematic due to their capability to form biofilms on implants. This study investigates the efficacy of an innovative silver nitrate-embedded poly-L-lactide biopolymer coating designed to prevent such infections. The methods involved applying varying concentrations of silver nitrate to in vitro setups and recording the resultant bacterial growth inhibition across different serum environments, including human serum and various animal sera. Results highlighted a consistent and significant inhibition of S. epidermidis growth at all tested concentrations in each type of serum without adverse interactions with serum proteins, which commonly compromise antimicrobial efficacy. This study concludes that the silver nitrate-embedded biopolymer coating exhibits potent antibacterial properties and has potential for use in clinical settings to reduce the incidence of PJIs. Furthermore, the findings underscore the importance of considering serum interactions in the design and testing of antimicrobial implants to ensure their effectiveness in actual use scenarios. These promising results pave the way for further research to validate and refine this technology for clinical application, focusing on optimizing silver ion release and assessing biocompatibility in vivo.